NORTHERN TRUST CORP - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$3,441,323
-6.9%
1,132,014
+0.8%
0.00%0.0%
Q2 2023$3,696,285
+26.0%
1,123,491
+21.8%
0.00%0.0%
Q1 2023$2,934,376
-45.7%
922,760
+18.2%
0.00%0.0%
Q4 2022$5,402,977
+25.4%
780,777
+14.7%
0.00%0.0%
Q3 2022$4,309,000
+64.3%
680,719
+7.5%
0.00%0.0%
Q2 2022$2,622,000
-23.0%
633,234
-9.8%
0.00%0.0%
Q1 2022$3,406,000
-52.6%
702,232
-2.5%
0.00%0.0%
Q4 2021$7,193,000
-47.5%
719,985
+0.3%
0.00%
-50.0%
Q3 2021$13,713,000
-41.7%
717,637
-2.4%
0.00%
-50.0%
Q2 2021$23,519,000
+146.8%
735,402
+132.7%
0.00%
+100.0%
Q1 2021$9,528,000
-29.8%
316,022
+0.8%
0.00%
-33.3%
Q4 2020$13,566,000
-21.0%
313,515
-1.5%
0.00%
-25.0%
Q3 2020$17,166,000
-12.5%
318,192
-1.0%
0.00%
-20.0%
Q2 2020$19,612,000
+54.9%
321,296
+16.6%
0.01%
+25.0%
Q1 2020$12,664,000
-43.9%
275,563
+7.1%
0.00%
-20.0%
Q4 2019$22,581,000
-2.7%
257,328
+1.8%
0.01%
-16.7%
Q3 2019$23,217,000
-31.4%
252,859
-5.0%
0.01%
-25.0%
Q2 2019$33,853,000
-18.8%
266,141
+0.4%
0.01%
-20.0%
Q1 2019$41,703,000
+62.7%
265,063
+2.6%
0.01%
+42.9%
Q4 2018$25,628,000
-31.4%
258,360
+0.9%
0.01%
-22.2%
Q3 2018$37,379,000
-1.2%
256,023
+6.3%
0.01%
-10.0%
Q2 2018$37,814,000
-62.6%
240,936
-59.3%
0.01%
-61.5%
Q1 2018$101,118,000
-3.7%
592,198
+0.4%
0.03%
-3.7%
Q4 2017$105,000,000
+36.6%
589,554
+5.3%
0.03%
+35.0%
Q3 2017$76,868,000
+41.1%
559,643
+7.9%
0.02%
+33.3%
Q2 2017$54,487,000
+29.0%
518,673
+11.7%
0.02%
+25.0%
Q1 2017$42,225,000
+50.2%
464,531
+2.0%
0.01%
+33.3%
Q4 2016$28,107,000
+0.7%
455,548
+10.6%
0.01%0.0%
Q3 2016$27,906,000
+59.5%
411,712
+1.9%
0.01%
+50.0%
Q2 2016$17,495,000
+167.0%
404,141
+172.4%
0.01%
+200.0%
Q1 2016$6,552,000
-23.9%
148,352
+10.7%
0.00%
-33.3%
Q4 2015$8,610,000
-24.1%
134,065
+1.1%
0.00%
-25.0%
Q3 2015$11,346,000
-73.6%
132,632
-48.0%
0.00%
-69.2%
Q2 2015$42,963,000
+23.7%
255,170
-11.2%
0.01%
+30.0%
Q1 2015$34,723,000
+59.1%
287,513
+20.9%
0.01%
+42.9%
Q4 2014$21,819,000
+148.2%
237,886
-2.9%
0.01%
+133.3%
Q3 2014$8,791,000
+144.8%
245,012
+163.1%
0.00%
+200.0%
Q2 2014$3,591,000
+75.3%
93,116
+3.3%
0.00%0.0%
Q1 2014$2,049,000
+1.6%
90,128
-6.2%
0.00%0.0%
Q4 2013$2,017,000
+106.0%
96,108
+164.7%
0.00%
Q3 2013$979,00036,3130.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders